609 related articles for article (PubMed ID: 29744964)
21. Improved assays to measure and characterize the inducible HIV reservoir.
Massanella M; Yek C; Lada SM; Nakazawa M; Shefa N; Huang K; Richman DD
EBioMedicine; 2018 Oct; 36():113-121. PubMed ID: 30316868
[TBL] [Abstract][Full Text] [Related]
22. From reactivation of latent HIV-1 to elimination of the latent reservoir: the presence of multiple barriers to viral eradication.
Shan L; Siliciano RF
Bioessays; 2013 Jun; 35(6):544-52. PubMed ID: 23613347
[TBL] [Abstract][Full Text] [Related]
23. A targeted reactivation of latent HIV-1 using an activator vector in patient samples from acute infection.
Mann JFS; Pankrac J; Klein K; McKay PF; King DFL; Gibson R; Wijewardhana CN; Pawa R; Meyerowitz J; Gao Y; Canaday DH; Avino M; Poon AFY; Foster C; Fidler S; Shattock RJ; Arts EJ
EBioMedicine; 2020 Sep; 59():102853. PubMed ID: 32654992
[TBL] [Abstract][Full Text] [Related]
24. Th1/17 Polarization of CD4 T Cells Supports HIV-1 Persistence during Antiretroviral Therapy.
Sun H; Kim D; Li X; Kiselinova M; Ouyang Z; Vandekerckhove L; Shang H; Rosenberg ES; Yu XG; Lichterfeld M
J Virol; 2015 Nov; 89(22):11284-93. PubMed ID: 26339043
[TBL] [Abstract][Full Text] [Related]
25. Limits on replenishment of the resting CD4+ T cell reservoir for HIV in patients on HAART.
Sedaghat AR; Siliciano JD; Brennan TP; Wilke CO; Siliciano RF
PLoS Pathog; 2007 Aug; 3(8):e122. PubMed ID: 17784786
[TBL] [Abstract][Full Text] [Related]
26. Measuring replication competent HIV-1: advances and challenges in defining the latent reservoir.
Wang Z; Simonetti FR; Siliciano RF; Laird GM
Retrovirology; 2018 Feb; 15(1):21. PubMed ID: 29433524
[TBL] [Abstract][Full Text] [Related]
27. Scientific rationale for antiretroviral therapy in 2005: viral reservoirs and resistance evolution.
Siliciano RF
Top HIV Med; 2005; 13(3):96-100. PubMed ID: 16170226
[TBL] [Abstract][Full Text] [Related]
28. Latently infected cell activation: a way to reduce the size of the HIV reservoir?
Forde J; Volpe JM; Ciupe SM
Bull Math Biol; 2012 Jul; 74(7):1651-72. PubMed ID: 22562387
[TBL] [Abstract][Full Text] [Related]
29. Modeling HIV persistence, the latent reservoir, and viral blips.
Rong L; Perelson AS
J Theor Biol; 2009 Sep; 260(2):308-31. PubMed ID: 19539630
[TBL] [Abstract][Full Text] [Related]
30. Stable Phenotypic Changes of the Host T Cells Are Essential to the Long-Term Stability of Latent HIV-1 Infection.
Seu L; Sabbaj S; Duverger A; Wagner F; Anderson JC; Davies E; Wolschendorf F; Willey CD; Saag MS; Goepfert P; Kutsch O
J Virol; 2015 Jul; 89(13):6656-72. PubMed ID: 25878110
[TBL] [Abstract][Full Text] [Related]
31. Blocking Formation of the Stable HIV Reservoir: A New Perspective for HIV-1 Cure.
Goonetilleke N; Clutton G; Swanstrom R; Joseph SB
Front Immunol; 2019; 10():1966. PubMed ID: 31507594
[TBL] [Abstract][Full Text] [Related]
32. The role of cytokines in the establishment, persistence and eradication of the HIV reservoir.
Vandergeeten C; Fromentin R; Chomont N
Cytokine Growth Factor Rev; 2012; 23(4-5):143-9. PubMed ID: 22743037
[TBL] [Abstract][Full Text] [Related]
33. Measuring the Frequency of Latent HIV-1 in Resting CD4⁺ T Cells Using a Limiting Dilution Coculture Assay.
Laird GM; Rosenbloom DI; Lai J; Siliciano RF; Siliciano JD
Methods Mol Biol; 2016; 1354():239-53. PubMed ID: 26714716
[TBL] [Abstract][Full Text] [Related]
34. In vivo analysis of the effect of panobinostat on cell-associated HIV RNA and DNA levels and latent HIV infection.
Tsai P; Wu G; Baker CE; Thayer WO; Spagnuolo RA; Sanchez R; Barrett S; Howell B; Margolis D; Hazuda DJ; Archin NM; Garcia JV
Retrovirology; 2016 May; 13(1):36. PubMed ID: 27206407
[TBL] [Abstract][Full Text] [Related]
35. Recent developments in the search for a cure for HIV-1 infection: targeting the latent reservoir for HIV-1.
Siliciano JD; Siliciano RF
J Allergy Clin Immunol; 2014 Jul; 134(1):12-9. PubMed ID: 25117799
[TBL] [Abstract][Full Text] [Related]
36. Unintegrated HIV-1 provides an inducible and functional reservoir in untreated and highly active antiretroviral therapy-treated patients.
Petitjean G; Al Tabaa Y; Tuaillon E; Mettling C; Baillat V; Reynes J; Segondy M; Vendrell JP
Retrovirology; 2007 Aug; 4():60. PubMed ID: 17727722
[TBL] [Abstract][Full Text] [Related]
37. Peripheral T follicular helper Cells Make a Difference in HIV Reservoir Size between Elite Controllers and Patients on Successful cART.
García M; Górgolas M; Cabello A; Estrada V; Ligos JM; Fernández-Guerrero M; Barros C; López-Bernaldo JC; De La Hera FJ; Montoya M; Benito JM; Rallón N
Sci Rep; 2017 Dec; 7(1):16799. PubMed ID: 29196729
[TBL] [Abstract][Full Text] [Related]
38. Transforming Growth Factor β Signaling Promotes HIV-1 Infection in Activated and Resting Memory CD4
Yim LY; Lam KS; Luk TY; Mo Y; Lu X; Wang J; Cheung KW; Lui GCY; Chan DPC; Wong BCK; Lau TT; Ngan CB; Zhou D; Wong YC; Tan Z; Liu L; Wu H; Zhang T; Lee SS; Chen Z
J Virol; 2023 May; 97(5):e0027023. PubMed ID: 37042759
[TBL] [Abstract][Full Text] [Related]
39. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation.
Chomont N; El-Far M; Ancuta P; Trautmann L; Procopio FA; Yassine-Diab B; Boucher G; Boulassel MR; Ghattas G; Brenchley JM; Schacker TW; Hill BJ; Douek DC; Routy JP; Haddad EK; Sékaly RP
Nat Med; 2009 Aug; 15(8):893-900. PubMed ID: 19543283
[TBL] [Abstract][Full Text] [Related]
40. Enhanced culture assay for detection and quantitation of latently infected, resting CD4+ T-cells carrying replication-competent virus in HIV-1-infected individuals.
Siliciano JD; Siliciano RF
Methods Mol Biol; 2005; 304():3-15. PubMed ID: 16061962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
